Prostate Cancer Care
Prostate cancer is common—and when detected early, it’s often highly treatable. At Beautiful Orlando, Dr. Sabharwal provides screening and a personalized plan that may include minimally invasive approaches such as HIFU (prostate tissue ablation) and robotic-assisted surgery when appropriate.
Local SEO: Prostate cancer screening Kissimmee • Prostate cancer doctor Orlando • Urologist Osceola County • Prostate HIFU Central Florida
Early detection changes everything
In the United States, prostate cancer is one of the most commonly diagnosed cancers in men and is a leading cause of cancer death. That’s why screening conversations—especially for patients with higher risk—matter. :contentReference[oaicite:1]{index=1}
Screening decisions should be individualized. Many guidelines emphasize informed decision-making with your clinician, often centered around a PSA blood test. :contentReference[oaicite:2]{index=2}
If further evaluation is needed, we guide you through next steps—from diagnostic testing to treatment planning— with a clear, calm approach and patient-first support.
Screening and diagnosis
Prostate cancer screening commonly involves a PSA blood test. A digital rectal exam (DRE) may be performed as part of an evaluation, but recommendations vary and it’s not considered a stand-alone screening test in many guidelines. :contentReference[oaicite:3]{index=3}
PSA can be higher for several reasons (including benign enlargement or infection), so results must be interpreted in context. If PSA is abnormal, additional testing may be recommended. :contentReference[oaicite:4]{index=4}
A prostate biopsy can confirm cancer. Imaging such as MRI and other studies may help guide diagnosis and staging when needed. :contentReference[oaicite:5]{index=5}
When to seek evaluation
Early prostate cancer often causes no symptoms. If symptoms occur, they can include difficulty urinating, blood in urine or semen, and bone pain—especially in more advanced disease. :contentReference[oaicite:6]{index=6}
Changes in urinary stream, increased frequency, or trouble starting urination can also be related to benign prostate enlargement, which still deserves evaluation.
Blood in urine/semen, persistent pain, or significant new urinary symptoms should be discussed promptly with a clinician.
The right plan depends on your case
Treatment may include surgery, radiation, or minimally invasive tissue ablation approaches depending on cancer stage, risk group, overall health, and your goals. :contentReference[oaicite:7]{index=7}
High-Intensity Focused Ultrasound
HIFU uses focused ultrasound energy to thermally ablate targeted prostate tissue. The FDA granted De Novo classification for a “high intensity ultrasound system for prostate tissue ablation” (Sonablate 450) in 2015. :contentReference[oaicite:8]{index=8}
Candidacy depends on your diagnosis and treatment goals. Your physician will discuss whether focal/ablation approaches fit your situation.
Robotic-Assisted Prostatectomy
Robotic-assisted laparoscopic prostatectomy uses small incisions and robotic instruments to remove the prostate. Compared with open surgery, it often has short-term advantages like less blood loss and shorter recovery—while long-term outcomes can be similar. :contentReference[oaicite:9]{index=9}
Radiation Therapy
Radiation can be delivered externally (EBRT, including IMRT/IGRT) or internally (brachytherapy/“seeds”), and may be used alone or in combination depending on risk group and stage. :contentReference[oaicite:10]{index=10}
Frequently asked questions
What does prostate cancer screening usually involve?
Screening conversations often center around a PSA blood test. A DRE may be part of evaluation, but recommendations vary and it’s not generally used as a stand-alone screening test. :contentReference[oaicite:11]{index=11}
If my PSA is high, does that mean I have cancer?
Not necessarily. PSA can be elevated for multiple reasons (including benign enlargement or infection). Your clinician interprets PSA in context and may recommend additional testing. :contentReference[oaicite:12]{index=12}
How is prostate cancer confirmed?
A biopsy is commonly used to confirm cancer. Imaging (such as MRI) may be used to guide diagnosis and staging in appropriate cases. :contentReference[oaicite:13]{index=13}
Is HIFU FDA-approved to treat prostate cancer?
FDA marketing authorization for HIFU systems can be for a general indication of prostate tissue ablation (for example, De Novo DEN150011 in 2015). Treatment decisions and intended use depend on individual clinical context and physician guidance. :contentReference[oaicite:14]{index=14}
How does robotic surgery compare to open surgery?
Robotic prostatectomy can offer short-term advantages such as less blood loss, less pain, and quicker recovery, while long-term outcomes and side effects may be similar. :contentReference[oaicite:15]{index=15}
What types of radiation therapy are used for prostate cancer?
Common approaches include external beam radiation therapy (including IMRT/IGRT) and brachytherapy (“seeds”), depending on cancer risk and clinical goals. :contentReference[oaicite:16]{index=16}
References
- CDC — Screening for Prostate Cancer (PSA/DRE overview): https://www.cdc.gov/prostate-cancer/screening/index.html
- NCI — Prostate Cancer Screening (PDQ): https://www.cancer.gov/types/prostate/patient/prostate-screening-pdq
- American Cancer Society — Detection & Diagnosis: https://www.cancer.org/cancer/types/prostate-cancer/detection-diagnosis-staging/detection.html
- FDA — De Novo classification for high intensity ultrasound system for prostate tissue ablation (DEN150011): https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?ID=DEN150011
- American Cancer Society — Surgery for Prostate Cancer (robotic vs open): https://www.cancer.org/cancer/types/prostate-cancer/treating/surgery.html
- American Cancer Society — Radiation Therapy for Prostate Cancer: https://www.cancer.org/cancer/types/prostate-cancer/treating/radiation-therapy.html
- American Cancer Society — Key Statistics for Prostate Cancer: https://www.cancer.org/cancer/types/prostate-cancer/about/key-statistics.html